January 2022, Episode 109: New Data Alert on the Up-and-Coming Migraine Medication: Intranasal Zavegepant. While not yet approved for release, intranasal zavegepant has shown promise in some interesting and unique data points in the relief of acute migraine. What is zavegepant and what will it offer us that is different from the other medications made newly available?

Listen to Lindsay Weitzel, Ph.D. ask the tough questions of migraine clinical trial expert Timothy Smith, MD about this up-and-coming medication.